Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
恩考拉非尼/西妥昔单抗联合或不联合比美替尼治疗BRAF V600E突变转移性结直肠癌患者的疗效和安全性:一项AGEO真实世界多中心研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103696
Gallois, C; Bergen, E S; Auclin, É; Pernot, S; Higué, J; Trouilloud, I; Touchefeu, Y; Turpin, A; Mazard, T; Sartore-Bianchi, A; Prenen, H; Alberti, A; Pilla, L; Cuissy, S; Wookey, V; Perret, A; Melchior, C; Artru, P; Dubreuil, O; Drouillard, A; Doat, S; Lavolé, J; Basile, D; Perkins, G; Jary, M; Stintzing, S; Ros, J; Tougeron, D; Taieb, J